Boron Neutron Capture Therapy for Cancer: Current Status and Future Prospects
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (15 August 2023)
Special Issue Editors
2. Proton Medical Research Center, University of Tsukuba Hospital, Tsukuba 305-8576, Japan
Interests: proton therapy; radiation therapy; hyperthermia
2. Proton Medical Research Center, University of Tsukuba Hospital, Tsukuba 305-8576, Japan
Interests: neutron source; particle radiation therapy; radiation biology
2. Proton Medical Research Center, University of Tsukuba Hospital, Tsukuba 305-8576, Japan
Interests: neutron source; particle radiation therapy; radiation biology
Special Issues, Collections and Topics in MDPI journals
2. Proton Medical Research Center, University of Tsukuba Hospital, Tsukuba 305-8576, Japan
Interests: neutron source; particle radiation therapy; radiation biology
Special Issue Information
Dear Colleagues,
Boron neutron capture therapy has entered a new era with the commercialization of accelerator neutron sources. This special issue will cover the status of accelerator development, which has entered the practical stage, the clinical treatment for recurrent head and neck cancer initiated in Japan, new findings found by reactor therapy, and clinically relevant reviews. We also invite papers on malignant glioma, studies on new target diseases, principles and validation of newly developed neutron sources, and new findings on treatment simulation systems.
Prof. Dr. Hideyuki Sakurai
Dr. Hiroaki Kumada
Dr. Kei Nakai
Dr. Yoshitaka Matsumoto
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Dr. Yoshitaka Matsumoto
Dr. Kei Nakai
Prof. Dr. Hideyuki Sakurai
Dr. Hiroaki Kumada
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- boron neutron capture therapy
- accelerator
- reactor
- boron
- neutron
- radiation therapy
- particle radiation therapy
- cancer treatment
- recurrent head and neck cancer
- malignant brain tumor
- skin tumor
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
